Tesamorelin
A GHRH analog studied specifically for visceral fat reduction, lean body composition, and overnight recovery.
Targeted at the fat you can't train off.
Tesamorelin is the most-studied GHRH analog for visceral adipose tissue — the deep abdominal fat that sits around organs and resists diet and cardio. It works by amplifying your own overnight growth hormone pulse.
How it works
Tesamorelin is a stabilized analog of growth hormone releasing hormone. Rather than introducing synthetic growth hormone, it signals your pituitary to release more of your own — preserving the pulsatile rhythm and feedback loop your body already relies on.
Because that pulse peaks during deep sleep, dosing is nightly. The clinical literature is strongest around visceral adipose tissue, which is also the fat most associated with metabolic risk — so progress is often better measured by waist and labs than by scale weight.
What to expect
- CadenceOne self-administered subcutaneous injection nightly, typically five to seven nights per week.
- FormatTesamorelin acetate — a stabilized growth hormone releasing hormone (GHRH) analog.
- ResponseSleep and recovery often shift within weeks; visceral fat and composition changes are measured over 3–6 months.
- Good fit ifYou're carrying stubborn abdominal fat despite good habits and want a physiologic, clinician-monitored approach.
- Side-effect patternUsually well tolerated. Injection-site redness, mild joint achiness, or fluid retention can occur early and typically settle.
Who it's for
Tesamorelin is for adults whose habits are already solid but who are holding deep abdominal fat, and who want a monitored, physiologic option instead of exogenous HGH.
- Adults 30+ with stubborn visceral or abdominal fat despite consistent training.
- You want recovery and sleep support alongside composition change.
- You prefer stimulating your own growth hormone over taking synthetic HGH.
- Comfortable with a nightly at-home subcutaneous injection.
- —Active or recent malignancy without oncologist sign-off.
- —Currently pregnant, planning pregnancy, or breastfeeding.
- —Untreated pituitary disease or unmanaged diabetes.
- —Under 18, or otherwise not appropriate on clinician review.
Your first 90 days
Tesamorelin builds gradually. Sleep quality usually moves first, with visceral fat change measured across months rather than weeks.
- Days 1–30Nightly rhythm established
You dose just before bed while your clinician watches tolerance and any early fluid retention or joint achiness. Deeper sleep is often the first thing patients report.
- Days 31–60Recovery and energy improve
Training soreness clears faster and daytime energy steadies. Waist measurements are more useful than the scale at this stage.
- Days 61–90Composition change becomes measurable
Abdominal circumference and lean-to-fat ratio begin to shift. Your clinician reviews progress, labs if ordered, and whether to continue or cycle.
